NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer
(Q59138821)
scientific article published on 28 March 2014
scientific article published on 28 March 2014
Language:
Current Data About
NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer
other details
| description | scientific article published on 28 March 2014 |
External Links
| (P356) |
10.1016/J.CLON.2014.03.003
|
| (P698) |
24685344
|